Copyright
©The Author(s) 2004.
World J Gastroenterol. May 1, 2004; 10(9): 1292-1296
Published online May 1, 2004. doi: 10.3748/wjg.v10.i9.1292
Published online May 1, 2004. doi: 10.3748/wjg.v10.i9.1292
PN group (n = 12) | rhGH + PN group (n = 12) | |
General conditions | ||
Age (years) | 46.1 ± 13.6 | 50.3 ± 10.6 |
Sex (M/F) | 11/1 | 10/2 |
Body weight (kg) | 59.7 ± 9.3 | 64.3 ± 7.7 |
Operative methods | ||
Hepatic left lateral lobectomy | 0 | 1 |
Left hemihepatectomy | 2 | 2 |
Right hemihepatectomy | 1 | 1 |
Tumor or segmentectomy | 9 | 8 |
Intraoperative information | ||
Operation time (min) | 250.8 ± 126.4 | 203.3 ± 73.2 |
Intraoperative blood loss (mL) | 1331.7 ± 1704.8 | 966.7 ± 1031.4 |
Intraoperative blood transfusion (mL) | 1100.0 ± 1334.2 | 408.3 ± 609.7 |
Normal control group (n = 12) | PN group (n = 12) | rhGH+PN group (n = 12) | |||||
Preoperative | POD 1 | POD 6 | Preoperative | POD 1 | POD 6 | ||
AST (IU/L) | 26.0 ± 5 | 56.0 ± 27a | 761.0 ± 578 | 62.0 ± 32 | 55.0 ± 25a | 578.0 ± 206 | 56.0 ± 25 |
ALT (IU/L) | 27.0 ± 17 | 60.0 ± 36a | 749.0 ± 571 | 153.0 ± 95 | 42.0 ± 17a | 590.0 ± 273 | 154.0 ± 71 |
ALP (IU/L) | 94.0 ± 55 | 151.0 ± 87 | 145.0 ± 80 | 148.0 ± 65 | 105.0 ± 27 | 100.0 ± 33 | 113.0 ± 46 |
TBIL (µmol/L) | 17.4 ± 6.4 | 22.6 ± 9.0 | 52.5 ± 48.1 | 43.1 ± 37.4 | 20.5 ± 9.3 | 42.1 ± 41.6 | 30.2 ± 21.0 |
ALB (g/L) | 42.8 ± 4.0 | 39.8 ± 4.7 | 31.5 ± 3.3 | 34.0 ± 3.4 | 40.7 ± 3.5 | 32.4 ± 3.6 | 37.1 ± 5.0 |
Blood glucose (mmol/L) | 4.6 ± 0.6 | 4.8 ± 0.9 | 7.3 ± 3.5 | 5.3 ± 1.5 | 4.5 ± 0.6 | 7.0 ± 3.2 | 8.8 ± 5.2c |
Serum prealbumin (mg/L) | 279.8 ± 43.0 | 202.4 ± 32.3a | 158.3 ± 25.4 | 127.2 ± 13.4 | 204.5 ± 31.9a | 157.2 ± 23.0 | 156.4 ± 20.0c |
Serum transferrin (g/L) | 3.5 ± 0.5 | 2.5 ± 0.2a | 2.1 ± 0.3 | 1.8 ± 0.2 | 2.5 ± 0.2a | 2.2 ± 0.3 | 2.2 ± 0.3c |
Normal control group (n = 12) | PN group (n = 12) | rhGH+PN group (n = 12) | |||||
Tumor tissues | Adjacent non-tumor tissues | Liver biopsy specimens POD 6 | Tumor tissue | Adjacent non-tumor tissues | Liver biopsy specimens POD 6 | ||
ALB mRNA | 0.69 ± 0.05 | 0.38 ± 0.01a | 0.50 ± 0.06ac | 0.63 ± 0.05 | 0.38 ± 0.01a | 0.50 ± 0.06ac | 0.71 ± 0.06e |
Liver Ki67 LI (%) | 0 | 17.4 ± 6.1a | 0.20 ± 0.1ac | 4.60 ± 0.5 | 17.2 ± 5.9a | 0.20 ± 0.1ac | 5.50 ± 0.5e |
- Citation: Luo SM, Liang LJ, Lai JM. Effects of recombinant human growth hormone on remnant liver after hepatectomy in hepatocellular carcinoma with cirrhosis. World J Gastroenterol 2004; 10(9): 1292-1296
- URL: https://www.wjgnet.com/1007-9327/full/v10/i9/1292.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i9.1292